Advertisement · 728 × 90
#
Hashtag
#bioconjugates
Advertisement · 728 × 90
Preview
Piramal Pharma Solutions Strengthens Bioconjugate Capabilities with IntoCell Partnership Piramal Pharma Solutions collaborates with IntoCell to enhance its bioconjugate offerings and advance innovative drug technologies, particularly ADCs.

Piramal Pharma Solutions Strengthens Bioconjugate Capabilities with IntoCell Partnership #India #Mumbai #Piramal_Pharma #bioconjugates #IntoCell

0 0 0 0
Preview
WuXi XDC Reports Strong Revenue Growth and Continued Market Leadership in Bioconjugates for H1 2025 WuXi XDC showcases impressive financial performance in the first half of 2025, highlighting significant growth in revenue and market expansion in the bioconjugates sector.

WuXi XDC Reports Strong Revenue Growth and Continued Market Leadership in Bioconjugates for H1 2025 #China #Shanghai #WuXi_XDC #CRDMO #bioconjugates

0 0 0 0
Preview
WuXi XDC Completes Mechanical Milestone in Singapore, Enhancing Global Bioconjugate Manufacturing Expansion WuXi XDC marks a significant milestone with the completion of its Singapore facility, set to boost global bioconjugate manufacturing capacities. Operations start in late 2025.

WuXi XDC Completes Mechanical Milestone in Singapore, Enhancing Global Bioconjugate Manufacturing Expansion #Manufacturing #Singapore #WuXi_XDC #bioconjugates

0 1 0 0
Preview
Piramal Pharma's Strategic $90M Investment for US Expansion in 2025 Piramal Pharma continues its focus on US innovation with a $90 million investment aimed at expanding two key facilities, enhancing capabilities in drug development.

Piramal Pharma's Strategic $90M Investment for US Expansion in 2025 #USA #Piramal_Pharma #bioconjugates #US_Expansion #Kentucky,_Michigan

0 0 0 0
Preview
Piramal Pharma Limited Boosts U.S. Presence with $90 Million Investment in Two Key Facilities Piramal Pharma Limited announces a $90 million investment for expanding two vital U.S. facilities. This strategic move aims to enhance its manufacturing capabilities and meet growing demand.

Piramal Pharma Limited Boosts U.S. Presence with $90 Million Investment in Two Key Facilities #USA #Piramal_Pharma #bioconjugates #ADCelerate #Lexington,_KY_and_Riverview,_MI

0 0 0 0